High-resolution magnetic resonance vessel wall imaging in extracranial cervical artery dissection
- PMID: 40070669
- PMCID: PMC11893369
- DOI: 10.3389/fneur.2025.1536581
High-resolution magnetic resonance vessel wall imaging in extracranial cervical artery dissection
Abstract
Extracranial cervical artery dissection (eCAD) is the second leading cause of stroke in young and middle-aged adults. Clinical management strategies for eCAD are continuously being explored and optimized, as revealed by the recently published CADISS and TREAT-CAD studies. The type of drug, dosage, and timing of administration can affect the regression of carotid artery dissection and the risk of recurrence of stroke. Based on imaging evidence, it is important to develop individualized treatment strategies for different risk groups. Currently, High-resolution magnetic resonance vessel wall imaging (MR-VWI) technology has made significant progress in the qualitative diagnosis of eCAD, vascular lesion progression, and the assessment of recurring ischemic stroke risk. To better understand the pathogenesis and progression of eCAD using MR-VWI, a comprehensive review is presented here.
Keywords: black blood; cervical artery dissection; intramural hematoma; ischemic stroke; vessel wall imaging.
Copyright © 2025 Shao and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
-
- Markus HS, Levi C, King A, Madigan J, Norris J. For the cervical artery dissection in stroke study (CADISS) investigators. Antiplatelet therapy vs anticoagulation therapy in cervical artery dissection: the cervical artery dissection in stroke study (CADISS) randomized clinical trial final results. JAMA Neurol. (2019) 76:657–64. doi: 10.1001/jamaneurol.2019.0072, PMID: - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
